Thermo Fisher Scientific Nivolumab Monoclonal Antibody (8G6G3D8)
니볼루맙을 인식하는 마우스 단클론 항체로, ELISA 등 연구용 분석에 적합합니다. 인간 PD-1 수용체 결합을 차단하여 면역 반응 활성화를 유도합니다. 동결건조 형태로 제공되며, 재구성 후 안정적인 사용이 가능합니다.
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Nivolumab Monoclonal Antibody (8G6G3D8)
Thermo Fisher Scientific Nivolumab Monoclonal Antibody (8G6G3D8)
Applications
- ELISA
Tested Dilution: 0.01–0.1 µg/mL
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Clone | 8G6G3D8 |
| Immunogen | Nivolumab |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Purification | Protein A |
| Storage Buffer | PBS, pH 7.4 |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C or -80°C if preferred |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Product Specific Information
Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
Nivolumab (Opdivo) is a humanized monoclonal antibody approved by the U.S. FDA for the treatment of unresectable or metastatic melanoma.
Nivolumab binds to the human cell surface receptor PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, resulting in activation of T-cell-mediated immune responses against tumor cells.
GenScript Anti-Nivolumab Antibody (8G6G3D8), mAb, Mouse is produced from a hybridoma formed by fusion of partner and B-lymphocytes obtained from a mouse immunized with Nivolumab.
Target Information
Nivolumab (Opdivo) is a humanized monoclonal antibody that binds to PD-1 (Programmed Cell Death Protein 1) and blocks its interaction with PD-L1, leading to activation of T-cell-mediated immune responses against tumor cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.